Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data and UPitt Cancer Institute Collaborate on Metabolomics Analysis

NEW YORK, Jan. 12 (GenomeWeb News) - Clinical Data will collaborate with the University of Pittsburgh Cancer Institute on a metabolomics study of lung cancer patients, the company said today.


Under the agreement, Clinical Data will apply metabolomics analysis to serum samples from a population of patients diagnosed with lung cancer and matched controls without lung cancer. UPCI will provide the serum samples.


Any new intellectual property or inventions from this study will remain the property of the discovering party, Clinical Data said. Both parties retain the rights to publish the results and disseminate information pertaining to the research conducted under the agreement.


The study is part of the National Caner Institute's Specialized Program of Research Excellence in Lung Cancer at UPCI.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.